About OCR
OCR is a company based in Loos (France) founded in 2011. OCR has raised $2.75 million across 2 funding rounds from investors including Newfund and Nord France Amorçage. OCR offers products and services including Clinical Studies, R&D Services, Histology, and Biobanking. OCR operates in a competitive market with competitors including Zoetis, Ceva, Bio-Sourcing, Phage Lab and Avecho, among others.
- Headquarter Loos, France
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$2.75 M (USD)
in 2 rounds
-
Latest Funding Round
$1.39 M (USD), Seed
Sep 06, 2016
-
Investors
Newfund
& 1 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of OCR
OCR offers a comprehensive portfolio of products and services, including Clinical Studies, R&D Services, Histology, and Biobanking.
Conducts trials for veterinary health advancements.
Supports innovation through biobanking and histology.
Performs tissue analysis for veterinary research.
Manages tissue samples for health studies.
People of OCR
Unlock access to complete
Product Management Team
1 people
Leadership Team
1 people
Directeur Team
1 people
Software Development Team
1 people
Unlock access to complete
Funding Insights of OCR
OCR has successfully raised a total of $2.75M across 2 strategic funding rounds. The most recent funding activity was a Seed round of $1.39 million completed in September 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in OCR
OCR has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Newfund and Nord France Amorçage.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage VC firm investing in geographies such as the US & France
|
Locked | Locked | Locked | |
|
A regional co-investment fund for innovative startups is managed.
|
Locked | Locked | Locked |
Investor details for OCR
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by OCR
Investment portfolio details for OCR
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - OCR
Detailed financials for OCR
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Ocr Comparisons
Peer comparison for OCR
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of OCR
OCR operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Zoetis, Ceva, Bio-Sourcing, Phage Lab and Avecho, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Animal medicines, vaccines, and diagnostics are manufactured and supplied.
|
|
| Locked | Locked | Locked |
Animal health therapeutics are developed and supplied globally by Ceva.
|
|
| Locked | Locked | Locked |
Biopharmaceuticals for animals are manufactured and supplied through partnerships.
|
|
| Locked | Locked | Locked |
Bacteriophage treatments for animal infections are developed by the company.
|
|
| Locked | Locked | Locked |
Developer of a drug delivery system for the safety of the animal and human health
|
|
| Locked | Locked | Locked |
Products enhancing animal productivity are developed and marketed.
|
Detailed competitors of OCR
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Ocr
Complete news archive for OCR
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about OCR
OCR was founded in 2011 and raised its 1st funding round 3 years after it was founded.
OCR is headquartered in Loos, France. It is registered at Loos, Nord, France.
OCR is a funded company, having raised a total of $2.75M across 2 funding rounds to date.
Manufacturer of medicines nutraceutical products for pet health. The company is involved in the development of drugs or therapeutic solutions for oncology, inflammation, cardiology, neurology, dermatology, pain more. It offers R D based services and biobank research tool for the identification of multiple diseases such as head neck carcinoma, soft tissue sarcomas, and more.
OCR's top competitors include Zoetis, Ceva and Bio-Sourcing.
OCR offers Clinical Studies, R&D Services, Histology, and Biobanking.
OCR has 2 investors. Key investors include Newfund, and Nord France Amorçage.